Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C192, UGT2B152 polymorphisms in breast cancer patients.

导出 OA

翻译打印收藏纠错

作者： Aleksandra,Markiewicz ^[1] ; Marzena,Wełnicka-Jaśkiewicz ; Jarosław,Skokowski ; Janusz,Jaśkiewicz ; Jolanta,Szade ; Jacek,Jassem ; Anna J,Zaczek

作者单位： Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, Gdańsk, Poland. ^[1]

主题词抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);芳基烃羟化酶类(Aryl Hydrocarbon Hydroxylases);乳房(Breast);乳腺肿瘤(Breast Neoplasms);无病生存(Disease-Free Survival);雌激素受体α(Estrogen Receptor alpha);女(雌)性(Female);基因扩增(Gene Amplification);基因剂量(Gene Dosage);葡糖醛酸基转移酶(Glucuronosyltransferase);人类(Humans);中年人(Middle Aged);多态现象, 遗传(Polymorphism, Genetic);预后(Prognosis);他莫昔芬(Tamoxifen)

DOI 10.1371/journal.pone.0072219

PMID 23951298

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览90

PloS one

2013年8卷8期

e72219页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C192, UGT2B152 polymorphisms in breast cancer patients.

PloS one

相似文献

PloS one

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients.

PloS one

相似文献

PloS one

相关期刊

检索历史清除

Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C192, UGT2B152 polymorphisms in breast cancer patients.